Biology Reference
In-Depth Information
Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB. 1995. CD28
costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:
87±98.
Borthwick NJ, Bo®ll M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson
MA, Janossy G. 1994. Lymphocyte activation in HIV-1 infection. II. Functional defects of
CD28
ÿ
T cells. AIDS 8: 431±441.
Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. 1996. The role of B7-1/B7-2:CD28/CLTA-4
pathways in the prevention of anergy, induction of productive immunity and down-regulation of
the immune response. Immunol Rev 153: 5±26.
Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, Picarella D, Hardy RR, Butcher EC.
2000. Developmental switches in chemokine response pro®les during B cell di¨erentiation and
maturation. J Exp Med 191: 1303±1318.
Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, Pace M, Sernicola L,
Koanga-Mogtomo ML, Betti M, Borsetti A, Belli R, Akerblom L, Corrias F, Butto S, Heeney
J, Verani P, Titti F, Ensoli B. 1999. Control of SHIV-89.6P-infection of cynomolgus monkeys
by HIV-1 Tat protein vaccine [see comments]. Nat Med 5: 643±650.
Casareale D, Sinagil F, Hedeskog M, Ward W, Volsky DJ. 1984. Establishement of retrovirus-,
Epstein-Barr virus positive B lymphastoid cell lines derived from individuals at risk for acquired
immune de®ciency syndrome (AIDS). AIDS Res 1: 253±270.
Caselli E, Betti M, Grossi MP, Balboni PG, Rossi C, Boarini C, Cafaro A, Barbanti-Brodano G,
Ensoli B, Caputo A. 1999. DNA immunization with HIV-1 tat mutated in the trans activation
domain induces humoral and cellular immune responses against wild-type Tat. J Immunol 162:
5631±5638.
Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, Cen B, Wu GX, Pei G. 2000. Beta-arrestin di¨erentially
regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and
this implicates multiple interaction sites between beta-arrestin and CXCR4. J Biol Chem 275:
2479±2485.
Chirmule N, Kalyanaraman VS, Saxinger C, Wong-Staal F, Ghrayeb J, Pahwa S. 1990. Localiza-
tion of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41. AIDS Res Hum
Retroviruses 6: 299±305.
Chirmule N, Kalyanaraman VS, Lederman S, Oyaizu N, Yagura H, Yellin MJ, Chess L, Pahwa S.
1993. HIV-gp 160-induced T cell-dependent B cell di¨erentiation. Role of T cell-B cell activation
molecule and IL-6. J Immunol 150: 2478±2486.
Chirmule N, Oyaizu N, Saxinger C, Pahwa S. 1994. Nef protein of HIV-1 has B-cell stimulatory
activity. AIDS 8: 733±734.
Cleary AM, Fortune SM, Yellin MJ, Chess L, Lederman S. 1995. Opposing roles of CD95 (Fas/
APO-1) and CD40 in the death and rescue of human low density tonsilar B cells. J Immunol 155:
3329±3337.
Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identi®cation of
RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by
CD8
T cells [see comments]. Science 270: 1811±1815.
Cohen OJ, Pantaleo G, Schwartzentruber DJ, Graziosi C, Vaccarezza M, Fauci AS. 1995. Patho-
genic insights from studies of lymphoid tissue from HIV-infected individuals [published erratum
appears in J Acquir Immune De®c Syndr Hum Retrovirol 1996; 11: 210]. J Acquir Immune De®c
Syndr Hum Retrovirol 10: S6±S14.
Combadiere C, Salzwedel K, Smith ED, Ti¨any HL, Berger EA, Murphy PM. 1998. Identi®cation
of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion
coreceptor for HIV-1. J Biol Chem 273: 23799±23804.
Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC,
Manfra DJ, Wiekowski MT, Sullivan LM, Smith SR, Greenberg HB, Narula SK, Lipp M, Lira
